[Psoriasis therapy with fumaric acid and fumaric acid esters]. by W Raab. Zeitschrift fur Hautkrankheiten. Read more related scholarly scientific articles and abstracts.
Fumaric acid esters for paediatric psoriasis
Fumaric acid esters (FAEs) are licensed for the treatment of moderate-to-severe psoriasis in Germany but are also used off-label in many other countries. We conducted this systematic review to synt...
Abstract Fumaric acid may not be regarded as an antipsoriatic drug. Beneficial effects on psoriatic lesions may be explained by secondary changes such as the acidification of gastric juice...
Fumaric acid esters (FAE) are chemical compounds derived from the unsaturated dicarbonic acid fumaric acid. The usage of FAEs in treatment of psoriasis was introduced in the late 1950's. In the 198...
[Immunomodulation with fumaric acid. Systemic therapy in psoriasis]. by B Sebók, I Schneider. Orvosi hetilap. Read more related scholarly scientific articles and abstracts.
The treatment of psoriasis vulgaris with fumaric acid esters has been controversial for more than 30 years. Recently the fumaric acid derivatives are marketed antipsoriatics in many European countr...
In studies, fumaric acid esters relieved the symptoms of plaque psoriasis in an estimated 30 to 40 out of 100 people. But the studies were small and weren’t carried out well, so these...
Systemic treatment of psoriasis with fumaric acid esters (FAE) has been found effective by empirical means. In recent years clinical studies have confirmed the antipsoriatic activity of a defined m...
Several clinical studies have shown that systemic therapy with fumaric acid esters (FAEs) in patients with moderate to severe psoriasis is effective and has a good long-term safety profile. For the...